Circulation, Vol 84, 1198-1202, Copyright © 1991 by American Heart Association
H el-Tamimi, GJ Davies, D Hackett, P Sritara, O Bertrand, F Crea and A Maseri
BACKGROUND. To study the impact of percutaneous transluminal coronary
angioplasty (PTCA) on coronary vasomotion, we prospectively analyzed
spontaneous changes in coronary diameter and the response to the cold
pressor test and intracoronary nitroglycerin in 11 patients subjected to
successful single-vessel PTCA. METHODS AND RESULTS. All antianginal
medications were stopped 48 hours before each study. The minimum diameter
of the PTCA segment and the diameter of a distal segment in the
angioplastied vessel and of a segment in a control vessel not manipulated
by the balloon catheter or guide wire were measured by computerized edge
detection immediately before PTCA and 5 minutes after, 4 hours after, and 8
days after PTCA. At 4 hours, PTCA and distal segments were constricted by
38 +/- 9% and 16 +/- 5%, respectively, compared with the values at 5
minutes (p less than 0.01). Before angioplasty, the cold pressor test
caused vasoconstriction of PTCA and distal segments by 23 +/- 6% (p less
than 0.0001) and 15 +/- 4% (p less than 0.008), respectively, but no
constrictor response was elicited at 5 minutes or 4 hours after
angioplasty. Eight days after PTCA, the basal coronary diameters were
similar to those observed 5 minutes after PTCA and the response to the cold
pressor test was similar to that observed before PTCA. All segments dilated
significantly with nitroglycerin at all times, and no vasoconstriction
changes were found in the control segments. CONCLUSIONS. Four hours after
PTCA, transient spontaneous vasoconstriction of the PTCA and distal
segments occurs, which is so intense that the cold pressor test does not
cause any further constriction. These abnormalities resolve within 8 days
of PTCA.
ARTICLES
Abnormal vasomotor changes early after coronary angioplasty. A quantitative arteriographic study of their time course
Cardiovascular Research Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
This article has been cited by other articles:
![]() |
S. E. Levy and J. A.S. Muldowney 3rd Microarray Analysis of Neointima: Flowing Toward a Clear Future Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 1946 - 1947. [Full Text] [PDF] |
||||
![]() |
E. D. Aymong, M. J. Curtis, M. Youssef, M. M. Graham, L. Shewchuk, W. Leschuk, and T. J. Anderson Abciximab Attenuates Coronary Microvascular Endothelial Dysfunction After Coronary Stenting Circulation, June 25, 2002; 105(25): 2981 - 2985. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Pereles, V. Kapoor, J. C. Carr, O. P. Simonetti, E. A. Krupinski, V. Baskaran, and J. P. Finn Usefulness of Segmented TrueFISP Cardiac Pulse Sequence in Evaluation of Congenital and Acquired Adult Cardiac Abnormalities Am. J. Roentgenol., November 1, 2001; 177(5): 1155 - 1160. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Nugent, H. M. Nugent, R. V. Iozzo, K. Sanchack, and E. R. Edelman Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia PNAS, June 6, 2000; 97(12): 6722 - 6727. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Heusch, D. Baumgart, P. Camici, W. Chilian, L. Gregorini, O. Hess, C. Indolfi, and O. Rimoldi {alpha}-Adrenergic Coronary Vasoconstriction and Myocardial Ischemia in Humans Circulation, February 15, 2000; 101(6): 689 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kosa, R. Blasini, J. Schneider-Eicke, T. Dickfeld, F. J. Neumann, S. Ziegler, I. Matsunari, J. Neverve, A. Schomig, and M. Schwaiger Early recovery of coronary flow reserve after stent implantation as assessed by positron emission tomography J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1036 - 1041. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Nugent, C. Rogers, and E. R. Edelman Endothelial Implants Inhibit Intimal Hyperplasia After Porcine Angioplasty Circ. Res., March 5, 1999; 84(4): 384 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Kern Appreciating {alpha}-Adrenergic Receptors and Their Role in Ischemic Left Ventricular Dysfunction Circulation, February 2, 1999; 99(4): 468 - 471. [Full Text] [PDF] |
||||
![]() |
J. Frielingsdorf, P. Kaufmann, T. Suter, R. Hug, and O. M. Hess Percutaneous Transluminal Coronary Angioplasty Reverses Vasoconstriction of Stenotic Coronary Arteries in Hypertensive Patients Circulation, September 22, 1998; 98(12): 1192 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Altstidl, C. Goth, H. Lehmkuhl, K. Bachmann, and R. Altstidl Quantitative Angiographic Analysis of PTCA-Induced Coronary Vasoconstriction in Single-Vessel Coronary Artery Disease Angiology, October 1, 1997; 48(10): 863 - 870. [Abstract] [PDF] |
||||
![]() |
D. Hasdai, D. R. Holmes, K. N. Garratt, W. D. Edwards, and A. Lerman Mechanical Pressure and Stretch Release Endothelin-1 From Human Atherosclerotic Coronary Arteries In Vivo Circulation, January 21, 1997; 95(2): 357 - 362. [Abstract] [Full Text] |
||||
![]() |
C. Rogers, S. Parikh, P. Seifert, and E. R. Edelman Endogenous Cell Seeding: Remnant Endothelium After Stenting Enhances Vascular Repair Circulation, December 1, 1996; 94(11): 2909 - 2914. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |